Previous close | 25.55 |
Open | 25.55 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 11.97 - 11.97 |
52-week range | 11.97 - 25.55 |
Volume | |
Avg. volume | 11 |
Market cap | 1.506B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 34.20 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 03 Oct 2024 |
1y target est | N/A |
As the United Kingdom's markets navigate through a period of anticipation ahead of key inflation data and regulatory discussions, investors remain attuned to shifts within the FTSE 100 and broader economic indicators. In such a climate, exploring growth companies with high insider ownership may offer valuable insights, particularly as these firms often demonstrate a strong alignment between management’s interests and those of their shareholders.
As the FTSE 100 shows signs of optimism, starting the week in positive territory ahead of key inflation figures, the broader market sentiment reflects cautious yet hopeful anticipation regarding upcoming economic data and corporate earnings. In such a market environment, growth companies with high insider ownership can be particularly compelling as they often indicate a strong alignment between company management and shareholder interests.
Kainos, a key NHS supplier, warned of weak demand from commercial clients in April and this was reflected in bookings.